Mirion Technologies
About: Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.
Employees: 2,860
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
245% more first-time investments, than exits
New positions opened: 100 | Existing positions closed: 29
85% more repeat investments, than reductions
Existing positions increased: 115 | Existing positions reduced: 62
62% more capital invested
Capital invested by funds: $2.76B [Q1] → $4.46B (+$1.71B) [Q2]
44% more call options, than puts
Call options by funds: $72.9M | Put options by funds: $50.8M
31% more funds holding
Funds holding: 229 [Q1] → 299 (+70) [Q2]
7.81% more ownership
Funds ownership: 84.12% [Q1] → 91.93% (+7.81%) [Q2]
14% less funds holding in top 10
Funds holding in top 10: 7 [Q1] → 6 (-1) [Q2]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
|
Goldman Sachs
Joe Ritchie
|
$25
|
Buy
Maintained
|
16 Sep 2025 |
|
Northland Capital Markets
Jeff Grampp
|
$26
|
Outperform
Initiated
|
25 Aug 2025 |
|
B. Riley Securities
Yuan Zhi
|
$22
|
Buy
Reiterated
|
23 Jul 2025 |
|
Citigroup
Andrew Kaplowitz
|
$24
|
Buy
Maintained
|
14 Jul 2025 |
|
Baird
Robert Mason
|
$22
|
Outperform
Maintained
|
9 Jul 2025 |
Financial journalist opinion
Based on 6 articles about MIR published over the past 30 days
